Denali Therapeutics Share Price (NASDAQ: DNLI)
$15.5
▲
0.27
(1.77%)
Last updated on
Check the interactive Denali Therapeutics Stock chart to analyse performance
Denali Therapeutics stock performance
as on August 23, 2025 at 1:29 AM IST
- Today's Low:$15.39Today's High:$16.10
0.71%
Downside
Day's Volatility :4.41%
Upside
3.73%
- 52 Weeks Low:$10.5752 Weeks High:$33.33
31.81%
Downside
52 Weeks Volatility :68.29%
Upside
53.5%
Denali Therapeutics Stock Returns
Denali Therapeutics Inc Key Stats
Check Denali Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Denali Therapeutics Stock including INR - Dollar returns
The Denali Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Denali Therapeutics investment value today
Current value as on today
₹66,892
Returns
Returns from Denali Therapeutics Stock
Dollar Returns*
₹4,316 (+4.32%)
Indian investors sentiment towards Denali Therapeutics Stock
Global Institutional Holdings in Denali Therapeutics Inc
Name
Holdings %
BlackRock Inc
9.50%
Baillie Gifford & Co Limited.
8.21%
Vanguard Group Inc
8.11%
FMR Inc
5.09%
T. Rowe Price Associates, Inc.
4.52%
UBS Asset Mgmt Americas Inc
4.30%
Analyst Recommendation on Denali Therapeutics Stock
Buy
86%Buy
13%Hold
0%Sell
Based on 23 Wall street analysts offering stock ratings for Denali Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Denali Therapeutics Share Price Target
What analysts predicted
Upside of 103.23%
Target:
$31.50
Current:
$15.50
Denali Therapeutics share price target is $31.50, a slight Upside of 103.23% compared to current price of $15.50 as per analysts' prediction.
Denali Therapeutics Stock Insights
Price Movement
In the last 7 days, DNLI stock has moved up by 3.6%Decreasing Revenue
Revenue is down for the last 3 quarters, 294.12M → -305.04M (in $), with an average decrease of 12137.8% per quarterIncreasing Net Profit
Netprofit is up for the last 2 quarters, -132.97M → -124.11M (in $), with an average increase of 7.1% per quarterDNLI vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 71.2% return, outperforming this stock by 109.7%DNLI vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 115.2% return, outperforming this stock by 167.6%
Denali Therapeutics Technicals Summary
Sell
Neutral
Buy
Denali Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Denali Therapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 6.46% | -25.06% | -37.46% | -50.05% | -53.62% |
 | 5.93% | -17.37% | -50.85% | -2.23% | -0.91% |
 | 5.81% | 21.35% | 61.84% | 78.01% | 32.14% |
 | -15.86% | -17.97% | -17.9% | 35.76% | 47.74% |
 | 42.31% | 82.49% | 66.63% | 105.56% | 244.81% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -3.01 | -0.4 | -0.25 | NA | 7.05 |
| 15.08 | 15.08 | 1.23 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.29 | -0.05 | -0.01 | NA | 34.32 |
| 28.25 | 28.25 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $2.2B | -53.62% | NA | 0.0% |
| Buy | $63.4B | -0.91% | 15.08 | 31.37% |
| NA | $38.2B | 32.14% | NA | -3.89% |
| Buy | $101.9B | 47.74% | 28.25 | 31.86% |
| Buy | $60.1B | 244.81% | NA | -12.96% |
Denali Therapeutics Dividend announcements
Denali Therapeutics Earnings
Denali Therapeutics’s price-to-earnings ratio stands at None
About Denali Therapeutics Inc
Key Management of Denali Therapeutics Inc
Important FAQs about investing in DNLI Stock from India :
What is Denali Therapeutics share price today?
Denali Therapeutics share price today is $15.50 as on at the close of the market. Denali Therapeutics share today touched a day high of $16.10 and a low of $15.39.
What is the 52 week high and 52 week low for Denali Therapeutics share?
Denali Therapeutics share touched a 52 week high of $33.33 and a 52 week low of $10.57. Denali Therapeutics stock price today i.e. is closed at $15.50, lower by 53.5% versus the 52 week high.
How to invest in Denali Therapeutics Stock (DNLI) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Denali Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Denali Therapeutics Shares that will get you 0.0968 shares as per Denali Therapeutics share price of $15.50 per share as on August 23, 2025 at 1:29 AM IST.
What is the minimum amount required to buy Denali Therapeutics Stock (DNLI) from India?
Indian investors can start investing in Denali Therapeutics (DNLI) shares with as little as ₹87.521 or $1 (as of August 23, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Denali Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 23, 2025).
Based on Denali Therapeutics share’s latest price of $15.50 as on August 23, 2025 at 1:29 AM IST, you will get 0.6452 shares of Denali Therapeutics. Learn more about
fractional shares .
What are the returns that Denali Therapeutics has given to Indian investors in the last 5 years?
Denali Therapeutics stock has given -53.62% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?
Discover More
Icahn Enterprises, L.p.$8.45
+1.81%
One Gas Inc$77.00
+2.35%
Borgwarner Inc.$43.13
+3.08%
Central Garden & Pet Co$36.61
+2.72%
Principal Us Mega-cap Etf$64.92
+1.15%
Sensient Technologies Corp$114.72
+0.31%
Brookfield Renewable Partners L.p.$25.43
+2.66%
Central Garden & Pet Co A Shares$33.19
+3.04%
Spdr S&p 400 Mid Cap Value E$84.05
+3.17%